The landscape of diabetes care is evolving with the introduction of GLP-1 patches . These innovative devices offer a potentially less invasive alternative to needle administrations for individuals dealing with diabetes 2. They deliver a GLP-1 agonist directly through the epidermis, circumventing the necessity for regular injections and possibly … Read More